Vous avez cherché: inhibiitoreid (Estonien - Anglais)

inhibiitoreid nagu
inhibitors such as

inhibiitoreid nagu dasatiniib ja
uch as dasatinib and nilotinib,

võib sisaldada kuni 0,1 % vahu inhibiitoreid.
may contain up to 0,1 % of antifoaming agents.

Ühelgi patsiendil ei tekkinud inhibiitoreid.
none of the patients developed inhibitors.

võivad sisaldada kuni 0,3 % vahu inhibiitoreid
may contain up to 0,3 % antifoaming agents.

Ärge võtke prootonpumba inhibiitoreid enne harvonit.
do not take proton pump inhibitors before harvoni.

- dihüdrofolaatreduktaasi inhibiitoreid (nt metotreksaat, trimetoprim)
- inhibitors of dihydrofolate reductase (e. g. methotrexate, trimethoprim)

ix faktori manustamine võib neid inhibiitoreid alla suruda.
the administration of factor ix can repress these inhibitors.

neil patsientidel tuleb sglt2 inhibiitoreid kasutada ettevaatusega.
sglt2 inhibitors should be used with caution in these patients.

annuse kohandamine mõõdukaid cyp3a inhibiitoreid kasutavatel patsientidel
dose adjustment for patients taking moderate cyp3a inhibitors

ake inhibiitoreid kasutatakse kõrge vererõhu või südamepuudulikkuse raviks.
ace inhibitors are used to treat high blood pressure or heart failure.

kui samaaegselt manustatakse cyp3a4 inhibiitoreid, tuleb olla ettevaatlik.
caution is advised if cyp3a4 inhibitors are given concomitantly.

ettevaatust tuleb rakendada, kui cyp3a4 inhibiitoreid manustatakse samaaegselt.
caution is advised if cyp3a4 inhibitors are given concomitantly.

ravimi vastunäidustatus samaaegselt cyp1a2 tugevaid inhibiitoreid saavatele patsientidele.
contra-indication in patients receiving concomitantly potent cyp1a2 inhibitors.

enamik neist patsientidest ei olnud proteaasi inhibiitoreid varem kasutanud.
most of these patients had not taken protease inhibitors in the past.

suure koormusega puhastist pärinevat või inhibiitoreid sisaldavat muda tuleks pesta.
if sludge has to be taken from a high rate treatment plant, or is thought to contain inhibitors, it should be washed.

astma või obstruktiivse kopsuhaigusega patsientidele tuleb koliinesteraasi inhibiitoreid määrata ettevaatusega.
cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease.

suure koormusega puhastusjaamast pärinevat või inhibiitoreid sisaldada võivat muda tuleks pesta.
if sludge has to be taken from a high rate treatment plant, or is thought to contain inhibitors, it should be washed.

koliinesteraasi inhibiitoreid, sealhulgas rivastigmiini, on nendel patsientidel seostatud kehakaalu langusega.
cholinesterase inhibitors, including rivastigmine, have been associated with weight loss in these patients.

uuringus tekkis inhibiitoreid ligikaudu 2%-l refacto af’i saanud patsientidest.
development of inhibitors occurred in approximately 2% of patients receiving refacto af in a research study.